Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function - Wikidata - wikimedia - TriplyDB

Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function

Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function

http://www.wikidata.org/entity/Q24647522

about

Managing bile acid diarrhoea Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis Brain-gut axis: from basic understanding to treatment of IBS and related disorders Current developments in pharmacological therapeutics for chronic constipation The interplay of the gut microbiome, bile acids, and volatile organic compounds Bile Acid diarrhea: prevalence, pathogenesis, and therapy Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled study Elobixibat and its potential role in chronic idiopathic constipation Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment.Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation.Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea.Recent advances in pharmacological treatment of irritable bowel syndrome.Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder.Bowel disturbances are the most important risk factors for late onset fecal incontinence: a population-based case-control study in women.Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.Systematic review: the management of chronic diarrhoea due to bile acid malabsorption.Advances in understanding of bile acid diarrhea.Commentary: fibroblast growth factor 19 in patients with bile acid diarrhoea Validating biomarkers of treatable mechanisms in irritable bowel syndrome LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea.A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation.Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders.Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation.Regulators of gut motility revealed by a gnotobiotic model of diet-microbiome interactions related to travel.Beneficial effect of sulphate-bicarbonate-calcium water on gallstone risk and weight control Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome Colesevelam improves oral but not intravenous glucose tolerance by a mechanism independent of insulin sensitivity and β-cell function.Therapeutic targeting of bile acids New and Emerging Treatment Options for Irritable Bowel Syndrome.Rationale for Investigating Stool Metabolites and Microbiota in Women With Fecal Incontinence.Advances in IBS 2016: A Review of Current and Emerging Data.Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations.The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes.Effect of TongXie-YaoFang on Cl(-) and HCO3 (-) Transport in Diarrhea-Predominant Irritable Bowel Syndrome Rats.Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.Enteroendocrine and neuronal mechanisms in pathophysiology of acute infectious diarrhea Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea.

P2860

Q24629001-DC920C84-231C-4B9F-A6F1-2736823D18A1 Q24635181-BC1E36B3-C94A-40D4-94F9-CD81DB92C14D Q27024801-F6F42A79-DACE-4195-B19B-535070E1C949 Q27025474-AE0F7D7E-55F6-44C4-9DD4-314D80437316 Q28082012-245636FF-B196-4CBA-A228-C6B375221959 Q28086845-8C3433C2-78D8-49F7-81E5-8DFF4040FA0B Q28242569-D4FE6293-55C9-4C48-954B-226DCDEE9F99 Q28244603-9DA259C5-7FC4-432B-BD3F-2E1B7EA6E49A Q33459719-2F91CEEB-7749-45AF-BAE5-5712AE082B1F Q33586854-8C7B2137-96F3-420F-B187-22AD4E27B80A Q33632959-E3A0B581-74CF-47A0-98A1-0FF2824C2BF1 Q33958853-FE964792-A804-44F3-A57F-97ED88D9BF4F Q34131127-E694E6C9-B769-4BB5-BF6F-D58EA84B1EE3 Q34142506-B1D95A90-20A5-4A94-A100-A9B0E493E5AF Q34258929-54AE1BCF-D463-4571-B9EA-04A07456F6AB Q34366988-F120D962-AB84-4A1B-8735-6E18A0FE748A Q34408666-FCF71A8F-B300-4C0C-A4DE-816487053C05 Q34412381-A42EFAC6-E773-47C7-8EB6-E1443C4312A1 Q34426461-B100EE94-CB3B-4CCA-8150-ADEDD278F26D Q34577283-9C97497E-E74A-47F5-9FDD-83680A46D507 Q34790812-BA489CFA-F02C-46EC-B388-940083FF57DD Q35028313-05763FAE-A299-42B0-BF33-A6505CA72736 Q35286303-1CFA4CC4-2CD6-4CCB-A6FA-E174E00E0320 Q35309093-1781E6FC-0CF9-451A-82C3-26BD2E66F235 Q35783889-4D53CC8E-55AF-4F68-A6E7-B17B56DDC183 Q35787894-0291A107-4D8C-4A3A-BFD8-2C464BBE269B Q35813485-C6A0A5BE-5BB1-4113-9360-C92BD9CC8E5E Q35817782-606D8C58-A609-4D6A-A906-244311022C91 Q35825711-9E43CA06-525E-4A82-A055-E651E40D1533 Q35898255-358AED55-8434-4472-9A0A-7167FCB63EED Q35958534-F50E7EE5-C439-4D57-81F0-903D15C14D45 Q36180769-C6D930F9-A3B5-4726-B3C5-DDC26FBB141A Q36242190-3A004E4F-5F27-4FCC-92B2-F69D7E5407D6 Q36245061-D04D8652-5C22-43ED-BFD4-2588621F44BA Q36487263-0D9AE099-12A7-4233-BB0A-00246358FA3C Q36720538-0143D1A4-E3F8-475D-B03A-9E93267E8A60 Q37043915-B44DB9AE-6914-4EFC-95AD-7DF91C69E66F Q37185328-340A5472-8BE1-43FD-997C-90958935E585 Q37259143-610DA015-A83B-4DF8-9A9D-468A3678228B Q37259375-2212A4EB-BB7E-416B-AB06-737D0DD9C48F

P2860

Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function

http://www.wikidata.org/entity/Q24647522

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Effects of chenodeoxycholate a ...... nal transit and bowel function

@ast

Effects of chenodeoxycholate a ...... nal transit and bowel function

@en

Effects of chenodeoxycholate a ...... nal transit and bowel function

@nl

type

label

Effects of chenodeoxycholate a ...... nal transit and bowel function

@ast

Effects of chenodeoxycholate a ...... nal transit and bowel function

@en

Effects of chenodeoxycholate a ...... nal transit and bowel function

@nl

prefLabel

Effects of chenodeoxycholate a ...... nal transit and bowel function

@ast

Effects of chenodeoxycholate a ...... nal transit and bowel function

@en

Effects of chenodeoxycholate a ...... nal transit and bowel function

@nl

P1433

Q24647522-56E3EE9B-5745-45FA-B0C1-99DCC22E018D

P1476

Q24647522-D16E2C58-D6AA-42EF-8E05-E1E9A1BE873F

P2093

Q24647522-09599037-837D-40C1-BD1B-BEED2B5CB5A7

Q24647522-2BC1E979-11EE-4506-8B32-A84CC53DED44

Q24647522-384C02A3-BACA-480A-9416-FA477A3E3B60

Q24647522-3AAEEAEE-0877-4BAA-912E-A17DC85B715F

Q24647522-71260785-43ED-4C0D-A9F9-43860AC316CD

Q24647522-94696A63-6A44-48BC-A4B1-CEBD544D6BCF

Q24647522-BA498444-D0DD-4E6F-8BE8-F54239733A5A

P2860

Q24647522-005D8633-D61B-4A0D-AAC0-C32A0F846D41

Q24647522-0066ADF7-606D-418F-AE41-1FDEC89849C9

Q24647522-096EFCC1-413F-4D8C-BACD-8C2703D8C3E6

Q24647522-0D2AA3A0-5BC6-4037-9F18-588935B652AD

Q24647522-1AEF9AFD-B240-49F4-A2BE-D5B4D4A415E2

Q24647522-2AF67FD8-B6C0-41DA-AE40-1DD2FA823AD9

Q24647522-3AD103D5-95B2-4D1D-BFEA-64840B32F3F1

Q24647522-4A7C6CF2-970D-44D2-AF71-2BF858179592

Q24647522-4B732E6A-6903-4E11-B066-3D0DE8859CD2

Q24647522-4C8EC7B0-C4CF-4DA2-A84E-924A73BD8121

P304

Q24647522-2561BE67-80B6-4109-84F0-ABAF7159364B

P31

Q24647522-AC18E6F9-6CF7-47E3-A0A0-4B0EBC195763

P3181

Q24647522-CDF42E12-746B-483F-9559-43433F7AC5A8

P356

Q24647522-0AADEDA4-C3EF-49FD-8CEA-7BDFF605A791

P407

Q24647522-1500C94E-2251-474D-886B-227D0C25BC30

P433

Q24647522-B7E3B340-C699-498F-A25D-E6817398B411

P478

Q24647522-FEC935CD-E953-4F46-A01F-2B4318867BFB

P50

Q24647522-710EF3B9-1629-454B-89AA-17F8A185E468

Q24647522-CCBF0431-395A-4796-BDE1-2DFBC17185D2

P577

Q24647522-66D266AA-E521-47A2-9A48-6D059100020D

P5875

Q24647522-8BF61D2F-5315-4A99-9F9E-6995C189548D

P698

Q24647522-B8847899-A371-4F91-955B-2258FACE96A6

P932

Q24647522-1CA5C35C-B550-496D-8506-072F64E064E8

P3181

P356

J.CGH.2009.10.020

P1433

Clinical Gastroenterology and Hepatology

P1476

Effects of chenodeoxycholate a ...... nal transit and bowel function

@en

P2093

Duane Burton

http://www.w3.org/2001/XMLSchema#string

Irene A Busciglio

http://www.w3.org/2001/XMLSchema#string

Jesse Lamsam

http://www.w3.org/2001/XMLSchema#string

Paula Carlson

http://www.w3.org/2001/XMLSchema#string

Ravinder Singh

http://www.w3.org/2001/XMLSchema#string

Sanna McKinzie

http://www.w3.org/2001/XMLSchema#string

Suwebatu T Odunsi-Shiyanbade

http://www.w3.org/2001/XMLSchema#string

P2860

Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man

The hospital anxiety and depression scale

The continuing importance of bile acids in liver and intestinal disease

Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy

Stool form scale as a useful guide to intestinal transit time

Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias

Treatment of constipation with chenodeoxycholic acid

Postcholecystectomy symptoms. A prospective study of gall stone patients before and two years after surgery.

Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion.

Bowel function and irritable bowel symptoms after hysterectomy and cholecystectomy--a population based study.

P304

159-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

817729

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CGH.2009.10.020

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Alan R. Zinsmeister

Michael Camilleri

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38058232

http://www.w3.org/2001/XMLSchema#string

P698

19879973

http://www.w3.org/2001/XMLSchema#string

P932

2822105

http://www.w3.org/2001/XMLSchema#string